October 25, 2017 - iuvo BioScience is proud to be part of the 2017 MedTech Annual Meeting, which scheduled for October 30-31, 2017, at the Hyatt Regency Buffalo, Buffalo, NY. The theme for this year’s annual meeting is “DisruptNY: Harnessing the Power of Partnership” and it is shaping up to be a very engaging and useful meeting.
Ben Burton, iuvo's President / CEO, is co-leading the development of the Start-up Track for the meeting with Bill Rader, President of Efferent Labs. The intent of the Start-up Track is to provide opportunities for the audience to learn, at a high level, what it takes to take a medical device from Concept to Commercialization. In addition to great content around Regulatory Strategy, Design Control, Commercialization needs and many other topics, Dr. Mary Richardson (Executive Vice President and CSO, iuvo BioScience) will present an overview of ISO-10993 testing required for a medical device company to gain approval for their device.
More details are available on the MedTech website here.